A treatment for allergic rhinitis: a view on the role of levocetirizine
- PMID: 16004679
- DOI: 10.1185/030079905X53298
A treatment for allergic rhinitis: a view on the role of levocetirizine
Abstract
Background: Allergic rhinitis is a significant public health concern in many developed countries. However, despite evidence for a significant impact on patients' quality of life (QoL) including sleep disruption and reduced daytime performance, allergic rhinitis remains under-managed and hence poorly controlled. This is largely owing to lack of knowledge about, and poor adherence to, established treatment guidelines.
Scope: The panel considered available evidence and focused on four published studies on the second-generation antihistamine, levocetirizine. Three of these studies explored the clinical impact of levocetirizine in a broad range of different clinical settings.
Findings: Levocetirizine demonstrated an increased benefit over other antihistamines in terms of a more durable antihistamine response: levocetirizine provided improved symptom relief at 24 hours compared to desloratadine or fexofenadine, two frequently prescribed second-generation antihistamines. Levocetirizine also maintained relief of the key symptoms of allergic rhinitis and improved patients' QoL over a treatment period of 6 months, in a real-life setting. The variable efficacy and durability of response of different antihistamines arise from differing modulatory effects on the H(1)-receptor. The speed of relief of symptoms with levocetirizine is supported by the pharmacokinetic data, which shows that steady state plasma concentrations are achieved in a shorter period of time than other second-generation histamines (additionally levocetirizine T(max) is reached in 0.9 h).
Conclusion: These findings support both the short-term and long-term use of levocetirizine in the clinical management of allergic rhinitis. The World Health Organization (WHO) ARIA Guidelines (Allergic Rhinitis and its Impact on Asthma), recommend using a combination of a non-sedating antihistamine with a decongestant, or glucocorticosteroids for treating allergic rhinitis - with the order and combination of treatment depending on severity and duration of symptoms.
Similar articles
-
Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children.Clin Ther. 2009 Aug;31(8):1664-87. doi: 10.1016/j.clinthera.2009.08.015. Clin Ther. 2009. PMID: 19808127 Review.
-
Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis.J Allergy Clin Immunol. 2004 Oct;114(4):838-44. doi: 10.1016/j.jaci.2004.05.070. J Allergy Clin Immunol. 2004. PMID: 15480324 Clinical Trial.
-
Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial.Ann Allergy Asthma Immunol. 2005 Aug;95(2):175-80. doi: 10.1016/S1081-1206(10)61208-2. Ann Allergy Asthma Immunol. 2005. PMID: 16136768 Clinical Trial.
-
Potential of levocetirizine in the relief of nasal congestion.Int J Clin Pract. 2005 Jun;59(6):721-9. doi: 10.1111/j.1368-5031.2005.00521.x. Int J Clin Pract. 2005. PMID: 15924602 Review.
-
Allergic rhinitis in family practice: the role of levocetirizine in clinical care.Postgrad Med. 2008 Jul;120(2):101-10. doi: 10.3810/pgm.2008.07.1797. Postgrad Med. 2008. PMID: 18654075 Review.
Cited by
-
A case of levocetirizine-induced liver injury.Clin Mol Hepatol. 2016 Dec;22(4):495-498. doi: 10.3350/cmh.2016.0023. Epub 2016 Dec 25. Clin Mol Hepatol. 2016. PMID: 28081586 Free PMC article.
-
Comparison of the risk of drowsiness and sedation between levocetirizine and desloratadine: a prescription-event monitoring study in England.Drug Saf. 2006;29(10):897-909. doi: 10.2165/00002018-200629100-00007. Drug Saf. 2006. PMID: 16970513 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources